已发表的部分文献: 标题:Epigenetic modifications of Nrf2-mediated glutamate-cysteine ligase: implications for the development of diabetic retinopathy and the metabolic memory phenomenon associated with its continued progression.作者:Mishra M, Zhong Q, Kowluru RA;杂志名称:Free Radic Biol Med 标题:Prenatal Iron Deficiency and Choline Supplementation Interact to Epigenetically Regulate Jarid1b and Bdnf in the Rat Hippocampus into Adulthood作者:Liu, S. et. al.;杂志名称:Nutrients 标题:H(2)S Alleviates Neuropathic Pain in Mice by Nrf2 Signaling Pathway Activation.作者:Wang J, Zhang N, Liu HZ, Wang JL, Zhang YB, Su DD, Miao J;杂志名称:J Mol Neurosci Epigentek 公司是全球领先的表观遗传学相关研究的技术创新者和产品开发供应商。开发了超过700多个专利产品,为表观遗传学方面的研究和新药研发提供全面系统的解决方案,涵盖样品制备、DNA/RNA甲基化(5-mc, 5-hmc, 5-fc, m6A)/DNMT分析、ChIP、组蛋白甲基化/乙酰化/去乙酰化/磷酸化/SUMO-等领域,提供小分子抑制剂、蛋白质、抗体、以及分析试剂盒产品。